HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Shogo Ishiuchi Selected Research
Shogo Ishiuchi Research Topics
Disease
16
Neoplasms (Cancer)
06/2022 - 09/2002
10
Glioblastoma (Glioblastoma Multiforme)
02/2015 - 09/2002
8
Glioma (Gliomas)
08/2017 - 10/2005
3
Astrocytoma (Pilocytic Astrocytoma)
08/2017 - 02/2008
2
Cognitive Dysfunction
08/2022 - 06/2022
1
Obesity
08/2022
1
Infratentorial Neoplasms (Posterior Fossa Tumors)
01/2018
1
Necrosis
08/2017
1
Diabetes Mellitus
04/2015
1
Hyperemia
02/2015
1
Cardiovascular Diseases (Cardiovascular Disease)
02/2015
1
Hypercholesterolemia
12/2014
1
Hyperglycemia
12/2014
1
Hypertension (High Blood Pressure)
12/2014
1
Myocardial Infarction
12/2014
1
Brain Neoplasms (Brain Tumor)
06/2014
1
Reperfusion Injury
01/2013
1
Infarction (Infarctions)
01/2013
1
Ischemia
01/2013
1
Dissection Internal Carotid Artery
11/2012
1
Subclavian Steal Syndrome (Subclavian Steal)
01/2012
1
Vertebrobasilar Insufficiency
01/2012
1
Dizziness (Lightheadedness)
01/2012
1
Intracranial Hemorrhages (Intracranial Hemorrhage)
01/2012
1
Pathologic Constriction (Stenosis)
01/2011
1
Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2010
1
Thrombocytopenia (Thrombopenia)
11/2010
1
B-Cell Lymphoma (Lymphoma, B Cell)
11/2010
1
Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
11/2010
1
Anaplasia
07/2007
1
Typical Teratoid Rhabdoid Tumor
07/2005
Drug/Important Bio-Agent (IBA)
5
AMPA Receptors (AMPA Receptor)
IBA
08/2022 - 09/2002
4
Proteins (Proteins, Gene)
FDA Link
01/2016 - 07/2005
4
Glutamate Receptors (Glutamate Receptor)
IBA
07/2009 - 09/2002
3
Glutamic Acid (Glutamate)
FDA Link
08/2022 - 05/2006
2
lysophosphatidic acid
IBA
12/2009 - 10/2005
2
Tensins
IBA
12/2009 - 02/2008
2
Phosphoric Monoester Hydrolases (Phosphatases)
IBA
12/2009 - 02/2008
2
sphingosine 1-phosphate (sphingosine-1-phosphate)
IBA
02/2008 - 10/2005
2
Complementary DNA (cDNA)
IBA
07/2007 - 09/2002
2
alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)
IBA
07/2007 - 09/2002
1
Calcium
IBA
08/2022
1
N-Methyl-D-Aspartate Receptors (NMDA Receptors)
IBA
08/2022
1
propionic acid (potassium propionate)
IBA
08/2022
1
Indocyanine Green (Cardio-Green)
FDA Link
Generic
01/2018
1
Reticulin (Reticular Fiber)
IBA
08/2017
1
Protein Kinase C-alpha
IBA
01/2016
1
choline transporter
IBA
01/2016
1
gamma-oryzanol
IBA
04/2015
1
Cell-Penetrating Peptides
IBA
02/2015
1
6-chloro-2-(1-piperazinyl)pyrazine (CPP)
IBA
02/2015
1
Coffee
FDA Link
02/2015
1
8-epi-prostaglandin F2alpha
IBA
12/2014
1
Angiotensin II
IBA
12/2014
1
Chemotactic Factors
IBA
12/2014
1
Nitric Oxide (Nitrogen Monoxide)
FDA Link
12/2014
1
Antineoplastic Agents (Antineoplastics)
IBA
06/2014
1
Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)
IBA
06/2014
1
Polysaccharides (Glycans)
IBA
06/2014
1
Poly Adenosine Diphosphate Ribose
IBA
06/2014
1
monodansylcadaverine
IBA
06/2014
1
6,7-dimethoxy-3-phenylquinoxaline
IBA
04/2013
1
YM 872
IBA
04/2013
1
Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)
IBA
04/2013
1
Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)
IBA
04/2013
1
salicylhydroxamic acid (SHAM)
IBA
01/2013
1
sannoshashinto
IBA
01/2013
1
Vincristine (Oncovin)
FDA Link
Generic
02/2012
1
Procarbazine (Matulane)
FDA Link
02/2012
1
Nimustine
IBA
02/2012
1
Thallium-201
IBA
06/2011
1
Chlorides
IBA
06/2011
1
Inosine Triphosphate (ITP)
IBA
11/2010
1
Cyclic AMP Receptors (Cyclic AMP Receptor)
IBA
12/2009
1
erythromycin propionate-N-acetylcysteinate
IBA
12/2009
1
Isoproterenol (Isoprenaline)
FDA Link
Generic
12/2009
1
Survivin
IBA
02/2009
1
Biomarkers (Surrogate Marker)
IBA
02/2009
1
amsonic acid (DAS)
IBA
08/2008
1
Carbon
IBA
08/2008
1
Antibodies
IBA
08/2008
1
Acids
IBA
05/2006
1
Phosphotransferases (Kinase)
IBA
10/2005
1
Lysophosphatidic Acid Receptors
IBA
10/2005
1
Mitogens
IBA
10/2005
1
Vimentin
IBA
07/2005
1
Messenger RNA (mRNA)
IBA
07/2005
1
Synaptophysin
IBA
07/2005
Therapy/Procedure
7
Therapeutics
06/2022 - 05/2003
6
Radiotherapy
06/2022 - 02/2009
3
Stents
11/2012 - 01/2011
2
Drug Therapy (Chemotherapy)
06/2014 - 02/2012
2
Aftercare (After-Treatment)
06/2014 - 04/2013
1
Adjuvant Chemoradiotherapy
08/2017
1
Lasers (Laser)
02/2015
1
Nephrectomy
12/2014
1
Kampo Medicine (Kampo)
01/2013
1
Hyperbaric Oxygenation
02/2012
1
Decompression
02/2012
1
Injections
06/2011